MeSH Browser

MeSH Supplementary: CAD protocol 2
Unique ID: C080874
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C080874
Entry Term(s): CAD regimen
Registry Number: 0
Heading Mapped to: *Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Lomustine; Vindesine
Frequency: 5
Note: chemotherapy protocol consisting of above compounds; used in treatment of Hodgkin's disease
Source: J Clin Oncol 1993 Apr;11(4):712-9
Date of Entry: 1993/05/21
Revision Date: 2000/11/30

CAD protocol 2 MeSH Supplementary Concept Data 2023